St. Jude Children ’s Research Hospital has a new clinical trial for relapsed leukemia

A specific type of drug-resistant, relapsed pediatric cancer is the focus of a new clinical trial at St. Jude Children's Research Hospital. The phase I/II clinical trial called RAVEN aims to research a new treatment option for children with relapsed acute lymphoblastic leukemia (ALL) — a severe cancer of blood and bone marrow that attacks white blood cells. According to Dr. Seth Karol, the trial's principal investigator and St. Jude associate faculty member, RAVEN uses a combination of traditional…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news